Agathos Biologics receives $300,000 from the 2023 North Dakota Bioscience Innovation Grant Program
September 27, 2023 (FARGO, N.D.) – Agathos Biologics, a biotechnology company developing transformational science within a strong ethical and moral framework, today announced the company has been awarded $300,000 from the 2023 North Dakota Department of Agriculture Bioscience Innovation Grant (BIG) Program. Agriculture Commissioner Doug Goehring announced that nine grants have been awarded totaling $8.4 million to foster the growth of the bioscience industry in North Dakota. “Advances in bioscience have already transformed many sectors including agriculture and medicine,” Goehring said. “These grants will help North Dakota stay on the forefront of bioscience innovation.”
This is the second North Dakota Bioscience Innovation Grant Agathos Biologics has received; the company was the recipient of $900,000 in 2021. The 2021 award provided critical support that allowed the company to launch its analytical services and develop the BHK-[wt E1] cell line for biomanufacturing, furthering the mission of the company to develop tools and technologies for drug development that avoid ethical concerns. This new award, which will fund capital equipment, enables further development of the BHK-[wt E1] cell line and manufacturing materials for sale, as well as our expanding analytical services.
“We are honored to receive this second grant from the State of North Dakota and thank the Commissioner and the Committee for their work on behalf of the citizens of the state,” said James Brown, Chief Executive Officer of Agathos Biologics. “We look forward to continuing to grow in North Dakota and pursue our goal to develop genetic medicine products and services that positively impact human health and are ethically acceptable to all.”